← Open Payments lookup

KRISTEN HOLLOWAY: Open Payments

NPI 1972086296 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$509 in 24 payments from 12 companies in 2025. Trend: 2023 $533 · 2024 $675 · 2025 $509

Food & beverage: $509
CompanyPaymentsAmount
Novo Nordisk Inc6$130
Bayer Healthcare Pharmaceuticals Inc.3$72
ABBVIE INC.3$62
Corcept Therapeutics2$45
Phathom Pharmaceuticals, Inc.1$36
Lilly USA, LLC2$34
Astellas Pharma US Inc1$28
Amgen Inc.2$27
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$22
PFIZER INC.1$20

Products named: Kerendia, Ozempic, VRAYLAR, Rybelsus, Korlym, VOQUEZNA, Cresemba, XIFAXAN.

Industry payments across AL — which companies pay providers there.